Cargando…
Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
BACKGROUND: Chronic liver injury induces pathological repair, resulting in fibrosis, during which hepatic stellate cells (HSCs) are activated and transform into myofibroblasts. CD248 is mainly expressed on myofibroblasts and was considered as a promising target to treat fibrosis. The primary aim of...
Autores principales: | Liu, Shaojie, Han, Donghui, Xu, Chao, Yang, Fa, Li, Yu, Zhang, Keying, Zhao, Xiaolong, Zhang, Jiayu, Lu, Tong, Lu, Shiqi, Shi, Changhong, Zhang, Rui, Yang, An-Gang, Zhao, Aizhi, Qin, Weijun, Yang, Bo, Wen, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939076/ https://www.ncbi.nlm.nih.gov/pubmed/35317721 http://dx.doi.org/10.1186/s10020-022-00460-1 |
Ejemplares similares
-
CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma
por: Liu, Shaojie, et al.
Publicado: (2021) -
CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021) -
CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation
por: Lu, Shiqi, et al.
Publicado: (2023) -
The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021) -
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)